CoChat
Sign Up
Cited by 1,332Pain Mechanisms and TreatmentsPain Management and TreatmentMusculoskeletal pain and rehabilitation

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Neuropathic pain: an updated grading system for research and clinical practice

Open access
Finnerup, Nanna B., Haroutounian, Simon, Kamerman, Peter, Baron, Ralf, Bennett, David L.H., Bouhassira, Didier, Cruccu, Giorgio, Freeman, Roy, Hansson, Per, Nurmikko, Turo, Raja, Srinivasa N., Rice, Andrew S.C., Serra, Jordi, Smith, Blair H., Treede, Rolf-Detlef, Jensen, Troels S.·2016·Pain
DOI 10.1097/j.pain.0000000000000492PMC PMC4949003
Open this paper in CoChat — free account

Abstract

The redefinition of neuropathic pain as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system,” which was suggested by the International Association for the Study of Pain (IASP) Special Interest Group on Neuropathic Pain (NeuPSIG) in 2008, has been widely accepted. In contrast, the proposed grading system of possible, probable, and definite neuropathic pain from 2008 has been used to a lesser extent. Here, we report a citation analysis of the original NeuPSIG grading paper of 2008, followed by an analysis of its use by an expert panel and recommendations for an improved grading system. As of February, 2015, 608 eligible articles in Scopus cited the paper, 414 of which cited the neuropathic pain definition. Of 220 clinical studies citing the paper, 56 had used the grading system. The percentage using the grading system increased from 5% in 2009 to 30% in 2014. Obstacles to a wider use of the grading system were identified, including (1) questions about the relative significance of confirmatory tests, (2) the role of screening tools, and (3) uncertainties about what is considered a neuroanatomically plausible pain distribution. Here, we present a revised grading system with an adjusted order, better reflecting clinical practice, improvements in the specifications, and a word of caution that even the “definite” level of neuropathic pain does not always indicate causality. In addition, we add a table illustrating the area of pain and sensory abnormalities in common neuropathic pain conditions and propose areas for further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/j.pain.0000000000000492

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Summary of how the citations of the neuropathic pain grading paper30 were used. The figure indicates the percentage of 608 publications that cited the original grading paper30 for defining neuropathic pain and the number of clinical studies that used the grading system for identifying neuropathic pain. The insert indicates the total number of clinical studies and the number of studies using the grading system30 for identifying neuropathic pain per year.
Figure 1. Summary of how the citations of the neuropathic pain grading paper30 were used. The figure indicates the percentage of 608 publications that cited the original grading paper30 for defining neuropathic pain and the number of clinical studies that used the grading system for identifying neuropathic pain. The insert indicates the total number of clinical studies and the number of studies using the grading system30 for identifying neuropathic pain per year.CC BY · PubMed Central
Figure 2. Flow chart of updated grading system for neuropathic pain. aHistory, including pain descriptors, the presence of nonpainful sensory symptoms, and aggravating and alleviating factors, suggestive of pain being related to a neurological lesion and not other causes such as inflammation or non-neural tissue damage. The suspected lesion or disease is reported to be associated with neuropathic pain, including a temporal and spatial relationship representative of the condition; includes paroxysmal pain in trigeminal neuralgia. bThe pain distribution reported by the patient is consistent with the suspected lesion or disease (Table 1). cThe area of sensory changes may extend beyond, be within, or overlap with the area of pain. Sensory loss is generally required but touch-evoked or thermal allodynia may be the only finding at bedside examination. Trigger phenomena in trigeminal neuralgia may be counted as sensory signs. In some cases, sensory signs may be difficult to demonstrate although the nature of the lesion or disease is confirmed; for these cases the level “probable” continues to be appropriate, if a diagnostic test confirms the lesion or disease of the somatosensory nervous system. dThe term “definite” in this context means “probable neuropathic pain with confirmatory tests” because the location and nature of the lesion or disease have been confirmed to be able to explain the pain. “Definite” neuropathic pain is a pain that is fully compatible with neuropathic pain, but it does not necessarily establish causality.
Figure 2. Flow chart of updated grading system for neuropathic pain. aHistory, including pain descriptors, the presence of nonpainful sensory symptoms, and aggravating and alleviating factors, suggestive of pain being related to a neurological lesion and not other causes such as inflammation or non-neural tissue damage. The suspected lesion or disease is reported to be associated with neuropathic pain, including a temporal and spatial relationship representative of the condition; includes paroxysmal pain in trigeminal neuralgia. bThe pain distribution reported by the patient is consistent with the suspected lesion or disease (Table 1). cThe area of sensory changes may extend beyond, be within, or overlap with the area of pain. Sensory loss is generally required but touch-evoked or thermal allodynia may be the only finding at bedside examination. Trigger phenomena in trigeminal neuralgia may be counted as sensory signs. In some cases, sensory signs may be difficult to demonstrate although the nature of the lesion or disease is confirmed; for these cases the level “probable” continues to be appropriate, if a diagnostic test confirms the lesion or disease of the somatosensory nervous system. dThe term “definite” in this context means “probable neuropathic pain with confirmatory tests” because the location and nature of the lesion or disease have been confirmed to be able to explain the pain. “Definite” neuropathic pain is a pain that is fully compatible with neuropathic pain, but it does not necessarily establish causality.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

Sorted by citations

See all 1,332

Related

See all

Metadata

Authors
Finnerup, N. B., Haroutounian, S., Kamerman, P., Baron, R., Bennett, D. L. H., Bouhassira, D., Cruccu, G., Freeman, R., Hansson, P., Nurmikko, T., Raja, S. N., Rice, A. S. C., Serra, J., Smith, B. H., Treede, R.-D., & Jensen, T. S.
Affiliations
  • Aarhus University (DK)
  • Washington University in St. Louis (US)
  • University of the Witwatersrand (ZA)
  • University Hospital Schleswig-Holstein (DE)
  • University of Oxford (GB)
  • Inserm (FR)
  • Sapienza University of Rome (IT)
  • Beth Israel Deaconess Medical Center (US)
  • Oslo University Hospital (NO)
  • Walton Centre (GB)
  • Johns Hopkins University (US)
  • Chelsea and Westminster Hospital NHS Foundation Trust (GB)
  • Neuroscience Technologies, Ltd, Barcelona, Spain
  • University of Dundee (GB)
  • Heidelberg University (DE)
Corresponding author
Finnerup, Nanna B.
ORCID
Venue
Pain
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2016-01-13
Volume
157
Issue
8
Pages
1599-1606
ISSN
  • 0304-3959 (ISSN-L)
  • 1872-6623
DOI
10.1097/j.pain.0000000000000492
PMC
PMC4949003
OpenAlex
W2316569153
Semantic Scholar
4d1325782b7eb15e39a0a2fafbff56c6b01dbb4c
Cited by
1,332
References
34
Citations by year
2026: 116 · 2025: 155 · 2024: 134 · 2023: 198 · 2022: 138 · 2021: 164 · 2020: 131 · 2019: 120 · 2018: 97 · 2017: 57 · 2016: 17
FWCI
11.40
Type
journal article
Language
en
Open access
Licence
Locations
  • Pain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Sanofi
  • International Association for the Study of Pain
  • Teva Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • European Commission (633491, HORIZON2020)
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • Eisai
  • Novo Nordisk (NNF14SA0006)
  • Astellas Pharma
  • Novo Nordisk Fonden (NNF14SA000 6, NNF14OC0011633)
  • Allergan
  • Sanofi Pasteur
  • National Institute of General Medical Sciences
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
neuropathic pain, neuropathic pain diagnosis, pain distribution, sensory disturbances, confirmatory testing, screening tool
MeSH terms
Humans, Neuralgia, Pain Measurement, Surveys and Questionnaires, Research, Pain Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropathic pain: an updated grading system for research and clinical practice. https://app.cochat.ai/papers/10.1097/j.pain.0000000000000492
The paper
Finnerup, N. B., Haroutounian, S., Kamerman, P., Baron, R., Bennett, D. L. H., Bouhassira, D., Cruccu, G., Freeman, R., Hansson, P., Nurmikko, T., Raja, S. N., Rice, A. S. C., Serra, J., Smith, B. H., Treede, R.-D., & Jensen, T. S. (2016). Neuropathic pain: an updated grading system for research and clinical practice. Pain. https://doi.org/10.1097/j.pain.0000000000000492